RESTORIGIN SX Trademark

Trademark Overview

On Friday, November 10, 2017, a trademark application was filed for RESTORIGIN SX with the United States Patent and Trademark Office. The USPTO has given the RESTORIGIN SX trademark a serial number of 87680163. The federal status of this trademark filing is SECTION 8 - ACCEPTED as of Thursday, August 8, 2024. This trademark is owned by Parametrics Medical, LLC. The RESTORIGIN SX trademark is filed in the Pharmaceutical Products category with the following description:

Human allograft tissue
restorigin sx

General Information

Serial Number87680163
Word MarkRESTORIGIN SX
Filing DateFriday, November 10, 2017
Status701 - SECTION 8 - ACCEPTED
Status DateThursday, August 8, 2024
Registration Number5591731
Registration DateTuesday, October 23, 2018
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 17, 2018

Trademark Statements

Goods and ServicesHuman allograft tissue
NOT AVAILABLE"SX"

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, November 21, 2017
Primary Code005
First Use Anywhere DateSunday, July 1, 2018
First Use In Commerce DateTuesday, July 31, 2018

Trademark Owner History

Party NameParametrics Medical, LLC
Party Type30 - Original Registrant
Legal Entity Type16 - Limited Liability Company
AddressLeander, TX 78641
Party NameParametrics Medical, LLC
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressKalamazoo, MI 49009
Party NameParametrics Medical, LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressKalamazoo, MI 49009

Trademark Events

Event DateEvent Description
Tuesday, February 27, 2018NON-FINAL ACTION E-MAILED
Tuesday, November 14, 2017NEW APPLICATION ENTERED
Tuesday, November 21, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, February 22, 2018ASSIGNED TO EXAMINER
Tuesday, February 27, 2018NON-FINAL ACTION WRITTEN
Tuesday, February 27, 2018NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, June 12, 2018NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Thursday, March 1, 2018EXAMINERS AMENDMENT -WRITTEN
Thursday, March 1, 2018EXAMINERS AMENDMENT E-MAILED
Thursday, March 1, 2018NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Thursday, March 1, 2018EXAMINER'S AMENDMENT ENTERED
Saturday, March 3, 2018APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, March 28, 2018NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, April 17, 2018PUBLISHED FOR OPPOSITION
Tuesday, April 17, 2018OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, July 31, 2018USE AMENDMENT FILED
Thursday, August 12, 2021APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, July 31, 2018TEAS STATEMENT OF USE RECEIVED
Wednesday, August 29, 2018CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, August 29, 2018STATEMENT OF USE PROCESSING COMPLETE
Monday, September 17, 2018ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Tuesday, September 18, 2018NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, October 23, 2018REGISTERED-PRINCIPAL REGISTER
Thursday, August 12, 2021TEAS CHANGE OF OWNER ADDRESS RECEIVED
Thursday, August 12, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, October 23, 2023COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Wednesday, August 7, 2024TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
Thursday, August 8, 2024REGISTERED - SEC. 8 (6-YR) ACCEPTED
Thursday, August 8, 2024NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
Thursday, August 1, 2024POST REGISTRATION ACTION MAILED - SEC. 8
Tuesday, January 30, 2024TEAS SECTION 8 RECEIVED
Tuesday, July 30, 2024CASE ASSIGNED TO POST REGISTRATION PARALEGAL

Related Keywords

restorigin tissue allograft human